DekaBank Deutsche Girozentrale
AVXL icon

DekaBank Deutsche Girozentrale’s Anavex Life Sciences AVXL Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-55,000
Closed -$449K – 1259
2023
Q1 		$449K Hold
55,000
– – ﹤0.01% 1028
2022
Q4 		$498K Hold
55,000
– – ﹤0.01% 1035
2022
Q3 		$522K Hold
55,000
– – ﹤0.01% 1035
2022
Q2 		$531K Hold
55,000
– – ﹤0.01% 1011
2022
Q1 		$675K Buy
55,000
+5,000
+10% +$61.5K ﹤0.01% 1000
2021
Q4 		$868K Buy
+50,000
New +$950K ﹤0.01% 966

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

DekaBank Deutsche Girozentrale's AVXL Position: Q2 2023 in Review

DekaBank Deutsche Girozentrale sold out of Anavex Life Sciences (AVXL) in Q2 2023, closing a stake of 55,000 shares — an estimated $449K sold.

DekaBank Deutsche Girozentrale first reported a position in AVXL in Q4 2021 and held it in 6 quarters. The position peaked at $868K in Q4 2021. 144 funds tracked by Wall St. Rank hold AVXL as of Q2 2023.

  • DekaBank Deutsche Girozentrale reported no remaining Anavex Life Sciences position as of Q2 2023 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 55,000 Anavex Life Sciences shares in Q2 2023, an estimated $449K.
  • DekaBank Deutsche Girozentrale first reported a position in Anavex Life Sciences in Q4 2021 and held it in 6 quarters.
  • DekaBank Deutsche Girozentrale's Anavex Life Sciences position peaked at $868K in Q4 2021.
  • 144 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2023.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2023, filed 25 Jul 2023.